SPL nasal spray can itself easily beats Remdesivir in efficiency. We do not need Remdesivir.
- Forums
- ASX - By Stock
- Trump given Remdesivir....an inferior product to Starpharma's DEP® remdesivir
SPL nasal spray can itself easily beats Remdesivir in...
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.4¢ |
Change
0.001(1.08%) |
Mkt cap ! $39.14M |
Open | High | Low | Value | Volume |
9.4¢ | 9.6¢ | 9.2¢ | $11.66K | 123.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 109 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.6¢ | 16930 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 109 | 0.094 |
1 | 28393 | 0.093 |
1 | 247718 | 0.092 |
1 | 48440 | 0.091 |
2 | 80000 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.096 | 16930 | 5 |
0.097 | 9391 | 2 |
0.098 | 19848 | 1 |
0.099 | 5360 | 2 |
0.100 | 52000 | 2 |
Last trade - 14.37pm 03/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online